<address id="ph9x9"></address>
    <form id="ph9x9"></form>

      <form id="ph9x9"></form>
          免費咨詢熱線

          15121004110

          技術文章

          TECHNICAL ARTICLES

          當前位置:首頁技術文章VEGF-B抗原,血管內皮生長因子B抗原

          VEGF-B抗原,血管內皮生長因子B抗原

          更新時間:2024-12-03點擊次數:139

          Recombinant Mouse VEGF-B   

          Vascular endothelial growth factor B; VEGF B; VEGFB; VEGF-B; VEGF related factor; VEGFL; Vrf; vascular endothelial growth factor B isoform VEGFB-167 precursor; VEGFB_HUMAN.     

          濃度:1mg/ ml

          來源:Recombinant Mouse

          純度:≥95% SDS-PAGE

          表達系統:Escherichia coli

          標簽:His tag

          蛋白長度:Full length protein

          內毒素水平:<1.000 Eu/µg

          純化方法:HPLC

          應用:SDS-PAGE,Western blot,ELISA

          Biological activity,immunology research

          保存:-20℃

          保質期:1年

          The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described and include fibroblast growth factor (FGF), platelet derived growth factor (PDGF) and vascular endothelial growth factors (VEGFs). The VEGF protein family is comprised of VEGF, VEGF-B, VEGF-C and VEGF-D, all of which may exhibit angiogenic function in vivo. VEGF-B, which exists as two alternatively spliced isoforms known as VEGF-B167 and VEGF-B186, is abundantly expressed in heart and skeletal muscle and is frequently co-expressed with VEGF. VEGF-C binds to and specifically activates Flt-4 and Flk-1.

              

          Recombinant Mouse VEGF-B   

          Vascular endothelial growth factor B; VEGF B; VEGFB; VEGF-B; VEGF related factor; VEGFL; Vrf; vascular endothelial growth factor B isoform VEGFB-167 precursor; VEGFB_HUMAN.     

          濃度:1mg/ ml

          來源:Recombinant Mouse

          純度:≥95% SDS-PAGE

          表達系統:Escherichia coli

          標簽:His tag

          蛋白長度:Full length protein

          內毒素水平:<1.000 Eu/µg

          純化方法:HPLC

          應用:SDS-PAGE,Western blot,ELISA

          Biological activity,immunology research

          保存:-20℃

          保質期:1年

          The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described and include fibroblast growth factor (FGF), platelet derived growth factor (PDGF) and vascular endothelial growth factors (VEGFs). The VEGF protein family is comprised of VEGF, VEGF-B, VEGF-C and VEGF-D, all of which may exhibit angiogenic function in vivo. VEGF-B, which exists as two alternatively spliced isoforms known as VEGF-B167 and VEGF-B186, is abundantly expressed in heart and skeletal muscle and is frequently co-expressed with VEGF. VEGF-C binds to and specifically activates Flt-4 and Flk-1.


          掃碼加微信

          服務熱線

          021-34553900

          上海市青浦區

          562398366@qq.com

          Copyright © 2025上海允麥生物科技有限公司 All Rights Reserved    備案號:滬ICP備20013035號-2

          技術支持:化工儀器網    管理登錄    sitemap.xml

          亚洲国产美女精品久久